Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1131-1140 of 1,835) with videos related to

Pageof 184
Sort By:
Mabs|November 30, 2023
Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseasesMaarten van der Linden, Sangeeta Kumari, Daphne Montizaan, et al.
Mabs|January 22, 2024
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodiesShen Luo, Baolin Zhang
Mabs|January 5, 2024
Antibodies to watch in 2024Silvia Crescioli, Hélène Kaplon, Alicia Chenoweth, et al.
Mabs|January 12, 2024
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-METAndreas Evers, Simon Krah, Deniz Demir, et al.
Mabs|December 12, 2023
Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancerGareth C G Davies, Neesha Dedi, Paul S Jones, et al.
Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.
Mabs|March 11, 2024
A pivotal decade for bispecific antibodies?Marlena Surowka, Christian Klein
Mabs|July 19, 2024
Modulation of the high concentration viscosity of IgG<sub>1</sub> antibodies using clinically validated Fc mutationsJoel Heisler, Daniel Kovner, Saeed Izadi, et al.
Mabs|August 24, 2024
The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeuticsDiana M Norden, Carmen T Navia, Jonathan T Sullivan, et al.
Mabs|July 4, 2024
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapyAmelia C McCue, Stephen J Demarest, Karen J Froning, et al.
Pageof 184

Showing results (1131-1140 of 1,835) with videos related to

Sort By:
Pageof 184
Mabs|November 30, 2023
Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseasesMaarten van der Linden, Sangeeta Kumari, Daphne Montizaan, et al.
Mabs|January 22, 2024
A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodiesShen Luo, Baolin Zhang
Mabs|January 5, 2024
Antibodies to watch in 2024Silvia Crescioli, Hélène Kaplon, Alicia Chenoweth, et al.
Mabs|January 12, 2024
Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-METAndreas Evers, Simon Krah, Deniz Demir, et al.
Mabs|December 12, 2023
Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancerGareth C G Davies, Neesha Dedi, Paul S Jones, et al.
Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.
Mabs|March 11, 2024
A pivotal decade for bispecific antibodies?Marlena Surowka, Christian Klein
Mabs|July 19, 2024
Modulation of the high concentration viscosity of IgG<sub>1</sub> antibodies using clinically validated Fc mutationsJoel Heisler, Daniel Kovner, Saeed Izadi, et al.
Mabs|August 24, 2024
The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeuticsDiana M Norden, Carmen T Navia, Jonathan T Sullivan, et al.
Mabs|July 4, 2024
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapyAmelia C McCue, Stephen J Demarest, Karen J Froning, et al.
Pageof 184